Oncology

Women older than age 65 face higher risk for several comorbidities from breast cancer treatment.

Recent advances and updates in oncology and cancer drug development.

Uncialamycin may effectively treat various cancer types, including gastric, lung, and ovarian cancers.

Blocking the chemokine CXCL1 resulted in slowed growth of obesity-related prostate cancer in mice models.

Individuals with primary immunodeficiency carry increased risk of developing a variety of cancers.

The drug eCF506 can selectively block the Src tyrosine kinase and stop the growth of breast cancer cells.

Larger waist circumference associated with an increased risk of aggressive prostate cancer.

Rapalink able to inhibit growth in drug-resistant tumors across different cancer types.

An antibody showed the ability to bind to the protein Bak and cause apoptosis.

Blocking the ERK1/2 pathway and the compensatory ERK5 pathway stopped the growth of colorectal tumors.

A method that involves a drug and a beam of ultraviolet light can kill 95% of cancer cells.

Sandoz announced efforts to create biosimilars for oncology and immunology branded drugs.

Specific blood-born microRNAs mutate before the development of hepatocellular carcinoma.

Overall survival of lung cancer patients in trial increased by 73%.

Sandoz to create biosimilars for 5 popular branded drugs.

Researchers examine the impact of aerobic and resistance training on cancer outcomes.

Liver cancer cells died when the AURKA-MYC interaction was inhibited.

Deficient copies of gene leaves some patients more susceptible for melanoma.

An antibody derived from the human immune system may kill cancer cells with less harm to patient.

Top news of the day from across the health care landscape.

Novel agents using dill and parsley extracts show promise fighting cancer.

Targeting cancer-driving proteins may further efforts in personalized cancer medication research.

Chemotherapy has the potential to make cancer cells more susceptible to immunotherapy.

Design of formulations based on flavopiridol shows promise inhibiting brain cancer cell growth.

Top news of the day from across the health care landscape.

Researchers explore which patients with non-small cell lung cancer are more likely to respond to the immunotherapy atezolizumab.

Fenofibrate with 2-Deoxy-D-glucose shows success treating a variety of cancers.

Higher doses of radiation found as effective as lower dose radiation for breast cancer treatment.